King Pharmaceuticals Inc Stock Price Prediction
| KG Stock | 25.28 0.49 1.98% |
Momentum 47
Impartial
Oversold | Overbought |
Using KING PHARMACEUTICALS hype-based prediction, you can estimate the value of KING PHARMACEUTICALS INC from the perspective of KING PHARMACEUTICALS response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in KING PHARMACEUTICALS to buy its stock at a price that has no basis in reality. In that case, they are not buying KING because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
KING PHARMACEUTICALS after-hype prediction price | USD 25.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out KING PHARMACEUTICALS Basic Forecasting Models to cross-verify your projections. KING PHARMACEUTICALS After-Hype Price Prediction Density Analysis
As far as predicting the price of KING PHARMACEUTICALS at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in KING PHARMACEUTICALS or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of KING PHARMACEUTICALS, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
KING PHARMACEUTICALS Estimiated After-Hype Price Volatility
In the context of predicting KING PHARMACEUTICALS's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on KING PHARMACEUTICALS's historical news coverage. KING PHARMACEUTICALS's after-hype downside and upside margins for the prediction period are 17.17 and 33.87, respectively. We have considered KING PHARMACEUTICALS's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
KING PHARMACEUTICALS is somewhat reliable at this time. Analysis and calculation of next after-hype price of KING PHARMACEUTICALS INC is based on 3 months time horizon.
KING PHARMACEUTICALS Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as KING PHARMACEUTICALS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading KING PHARMACEUTICALS backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with KING PHARMACEUTICALS, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 8.35 | 0.24 | 0.22 | 3 Events / Month | 3 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
25.28 | 25.52 | 0.95 |
|
KING PHARMACEUTICALS Hype Timeline
As of July 26, 2025 KING PHARMACEUTICALS INC is listed for 25.28. The entity has historical hype elasticity of 0.24, and average elasticity to hype of competition of 0.22. KING is forecasted to increase in value after the next headline, with the price projected to jump to 25.52 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.95%, whereas the daily expected return is now at 0.31%. The volatility of related hype on KING PHARMACEUTICALS is about 1184.4%, with the expected price after the next announcement by competition of 25.50. The company generated the yearly revenue of 5.25 M. Reported Net Income was 324.27 K with gross profit of 0. Allowing for the 90-day total investment horizon the next forecasted press release will be in about 3 days. Check out KING PHARMACEUTICALS Basic Forecasting Models to cross-verify your projections.KING PHARMACEUTICALS Related Hype Analysis
Having access to credible news sources related to KING PHARMACEUTICALS's direct competition is more important than ever and may enhance your ability to predict KING PHARMACEUTICALS's future price movements. Getting to know how KING PHARMACEUTICALS's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how KING PHARMACEUTICALS may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EGP | EastGroup Properties | 3.27 | 9 per month | 1.17 | (0.12) | 1.76 | (1.97) | 6.01 | |
| EML | Eastern Co | 0.31 | 10 per month | 1.67 | 0.03 | 3.54 | (2.74) | 14.34 | |
| CDR-PB | Cedar Realty Trust | 0.00 | 0 per month | 1.39 | (0.02) | 3.39 | (3.58) | 10.94 | |
| EL | Estee Lauder Companies | 0.63 | 7 per month | 1.45 | 0.21 | 5.33 | (3.30) | 14.71 | |
| NWL | Newell Brands | 0.00 | 0 per month | 2.76 | 0.05 | 8.05 | (4.72) | 21.37 | |
| SOCAU | Solarius Capital Acquisition | 0.02 | 2 per month | 0.00 | (1.57) | 0.20 | (0.10) | 0.30 |
KING PHARMACEUTICALS Additional Predictive Modules
Most predictive techniques to examine KING price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for KING using various technical indicators. When you analyze KING charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About KING PHARMACEUTICALS Predictive Indicators
The successful prediction of KING PHARMACEUTICALS stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as KING PHARMACEUTICALS INC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of KING PHARMACEUTICALS based on analysis of KING PHARMACEUTICALS hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to KING PHARMACEUTICALS's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to KING PHARMACEUTICALS's related companies. | 2010 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.0408 | 0.0367 | 0.0326 | Revenue Per Share | 0.17 | 0.16 | 0.14 |
Story Coverage note for KING PHARMACEUTICALS
The number of cover stories for KING PHARMACEUTICALS depends on current market conditions and KING PHARMACEUTICALS's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that KING PHARMACEUTICALS is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about KING PHARMACEUTICALS's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
KING PHARMACEUTICALS Short Properties
KING PHARMACEUTICALS's future price predictability will typically decrease when KING PHARMACEUTICALS's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of KING PHARMACEUTICALS INC often depends not only on the future outlook of the potential KING PHARMACEUTICALS's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. KING PHARMACEUTICALS's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.7 M | |
| Cash And Short Term Investments | 4.3 M |
Complementary Tools for KING Stock analysis
When running KING PHARMACEUTICALS's price analysis, check to measure KING PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KING PHARMACEUTICALS is operating at the current time. Most of KING PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of KING PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KING PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of KING PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |